Temat: everolimus - Katalog OPAC zbiorów

Skocz do pozycji: 1.

Tytuł:: Everolimus with exemestane in elderly breast cancer patients – case report
Autorzy:: Jagiełło-Gruszfeld, Agnieszka
Powiązania:: https://bibliotekanauki.pl/articles/1065836.pdf
Data publikacji:: 2014
Wydawca:: Medical Education
Tematy:: breast cancer
elderly
everolimus
exemestan
Opis:: Treating elderly patients suffering from metastatic breast cancer still constitutes a significant therapeutic problem. The possibility of administering everolimus in combination with exemestane appears to be a promising therapeutic option in the case of hormone-dependent cancers, without HER2 receptor overexpression.
Źródło:: OncoReview; 2014, 4, 1; A33-36
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 2.

Tytuł:: Everolimus – effectively reverses acquired resistance on endocrine therapy of patients with advanced breast cancer. A case report
Autorzy:: Grela-Wojewoda, Aleksandra
Kruczała, Maksymilian
Cedrych, Ida
Powiązania:: https://bibliotekanauki.pl/articles/1065382.pdf
Data publikacji:: 2014
Wydawca:: Medical Education
Tematy:: breast cancer
endocrine therapy
everolimus
Opis:: Breast cancer is the most common malignancy among women in Poland. Endocrine therapy is the first line of treatment in hormone-receptor-positive advanced breast cancer. Progression during endocrine therapy is unavoidable. Administration of mTOR inhibitor gives a chance of reversing the acquired resistance. This paper presents a case report of a patient with metastatic breast cancer successfully treated with everolimus added to endocrine therapy.
Źródło:: OncoReview; 2014, 4, 3; A117-120
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 3.

Tytuł:: Retrospective assessment of everolimus treatment in patients suffering from advanced renal cell carcinoma
Autorzy:: Hernik, Paweł
Kruczała, Maksymilian
Ziobro, Marek
Powiązania:: https://bibliotekanauki.pl/articles/773514.pdf
Data publikacji:: 2017
Wydawca:: Medical Education
Tematy:: everolimus
renal cell carcinoma
targeted therapy
Opis:: Objective: Results of second-line everolimus treatment in clear cell renal carcinoma. Material and methods: Clinical data of 32 patients of the Clinic of Systemic and Metastatic Malignancies, Centre of Oncology, Maria Sklodowska-Curie Memorial Institute (Krakow Branch) treated with second-line everolimus between 2011 and 2016 were analysed. Results: Median progression-free survival was 7 months. Stable disease was observed in 24 cases. Adverse events occurred in 59% of all patients, and the majority were mild and moderate (G1 and G2) according to CTCAE. The most frequent adverse events included anaemia, stomatitis, rash and fatigue. Conclusion: Molecularly targeted drugs offer the only effective and available therapy in Poland, which can be administered in patients with advanced renal cell carcinoma. Second-line everolimus is a valuable therapeutic option in the above mentioned group (following progression on first-line TKI therapy), especially when it is necessary to avoid the accumulation of similar adverse events after TKI treatment (different toxicity profiles).
Źródło:: OncoReview; 2017, 7, 2; 88-91
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Skocz do pozycji: 4.

Tytuł:: Everolimus-induced interstitial lung disease in patient with metastatic renal cell carcinoma – case report and literature review
Autorzy:: Buraczewska, Agnieszka
Kardas, Joanna
Powiązania:: https://bibliotekanauki.pl/articles/1065282.pdf
Data publikacji:: 2015
Wydawca:: Medical Education
Tematy:: everolimus
interstitial lung disease
metastatic renal cell carcinoma
Opis:: We present a case of a 70-year-old man with metastatic renal cell carcinoma treated with second-line everolimus after rapid progression on first-line tyrosine kinase inhibitor, in whom a side effect of the therapy occurred in the form of a drug-induced interstitial lung disease. We also provide a review of the literature concerning opinions on incidence, clinical picture, consequences and management of the complication discussed.
Źródło:: OncoReview; 2015, 5, 3; A117-121
2450-6125
Pojawia się w:: OncoReview
Dostawca treści:: Biblioteka Nauki

Artykuł

Zmień widok

na półce

Informacja

Wyszukujesz frazę "everolimus" wg kryterium: Temat

Źródło danych

Dostawca treści

Kolekcja

Rok wydania

Wydawca

Temat

Autor

Typ dokumentu

Język